Used in pharmaceutical research as a key intermediate in the development of central nervous system (CNS) active compounds. It serves as a structural analog in the design of ligands targeting serotonin and dopamine receptors, particularly for potential use in treating psychiatric disorders such as depression, anxiety, and schizophrenia. Its sulfonamide and piperidine moieties enhance binding selectivity and improve metabolic stability in drug candidates. Also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties of novel therapeutics.